Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 5/20 | 0.76 |
| ▸ | ATM | Q13315 | 2/20 | 0.76 |
| ▸ | CFTR | P13569 | 1/20 | 0.76 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.76 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.76 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | GNG2 | P59768 | 1/20 | 0.41 |
| ▸ | GNB1 | P62873 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5606345 | 1.00 | USP2 (0.76) | USP2ATMCFTRPAX8GOPC | |
| SCHEMBL458205 | 0.99 | ABCB1 (0.77) | USP2ATMCFTRPAX8GOPC | |
| Sulfuric Acid SCHEMBL16593429 | 0.95 | ABCB1 (0.71) | USP2ATMCFTRPAX8GOPC | |
| Sulfuric Acid SCHEMBL16593427 | 0.92 | ABCB1 (0.68) | USP2ATMCFTRPAX8GOPC | |
| SCHEMBL23309754 | 0.89 | ABCB1 (0.76) | USP2ATMCFTRPAX8GOPC | |
| SCHEMBL9979456 | 0.89 | ABCB1 (0.79) | USP2ATMCFTRPAX8GOPC | |
| SCHEMBL14693687 | 0.89 | ABCB1 (0.76) | USP2ATMCFTRPAX8GOPC | |
| Hydrochloric Acid SCHEMBL18816029 | 0.87 | USP2 (0.98) | USP2ATMCFTRPAX8GOPC | |
| Hydrochloric Acid SCHEMBL29363314 | 0.87 | USP2 (0.98) | USP2ATMCFTRPAX8GOPC | |
| Hydrochloric Acid SCHEMBL3808879 | 0.87 | USP2 (0.98) | USP2ATMCFTRPAX8GOPC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4624903-A1 | LIQUID SPRAY ANALYSIS | Rolls-Royce plc (GB) | 2025-10-01 | — | — | EP | claimed |
| US-20250297956-A1 | LIQUID SPRAY ANALYSIS | ROLLS-ROYCE PLC (GB) | 2025-09-25 | — | — | US | claimed |
| CN-116288357-B | Chromogenic corrosive liquid and preparation method and application thereof | 湖北亿纬动力有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-116948640-B | Method for preparing green light carbon quantum dots with ultrahigh fluorescence quantum yield by one-step hydrothermal method and application | 云南大学 | 2024-09-27 | — | — | CN | claimed |
| EP-4220164-B1 | METHODS AND SYSTEMS FOR QUANTITATIVE IMMUNOHISTOCHEMISTRY | VENTANA MED SYST INC (US) | 2024-08-21 | — | — | EP | claimed |
| EP-3391056-B1 | CHROMOGENIC PEROXIDASE SUBSTRATES | AGILENT TECHNOLOGIES INC (US) | 2024-01-17 | — | — | EP | claimed |
| EP-4056666-B1 | ELECTRICAL TERMINAL WITH PASSIVATION LAYER | APTIV TECH LTD (BB) | 2023-11-01 | — | — | EP | claimed |
| CN-116948640-A | Method for preparing green light carbon quantum dots with ultrahigh fluorescence quantum yield by one-step hydrothermal method and application | 云南大学 | 2023-10-27 | — | — | CN | claimed |
| CN-116718644-A | Carbon dioxide sensor material and device based on ion conduction gain effect | 华南师范大学 | 2023-09-08 | — | — | CN | claimed |
| US-20230201380-A1 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | UNM RAINFOREST INNOVATIONS (US) | 2023-06-29 | — | — | US | claimed |
| CN-116288357-A | Chromogenic corrosive liquid and preparation method and application thereof | 湖北亿纬动力有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-3555622-B1 | METHODS AND SYSTEMS FOR QUANTITATIVE IMMUNOHISTOCHEMISTRY | VENTANA MED SYST INC (US) | 2023-02-22 | — | — | EP | claimed |
| EP-4056666-A1 | ELECTRICAL TERMINAL WITH PASSIVATION LAYER | Aptiv Technologies Limited (BB) | 2022-09-14 | — | — | EP | claimed |
| CN-111072699-B | Hydroxyl radical ratio type fluorescent probe and preparation method and application thereof | 广州中医药大学(广州中医药研究院) | 2022-05-24 | — | — | CN | claimed |
| EP-3996815-A2 | HIV BINDING AGENTS | LAUSANNE UNIVERSITY HOSPITAL (CH) | 2022-05-18 | — | — | EP | claimed |
| EP-3980140-A2 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2022-04-13 | — | — | EP | claimed |
| US-12636373-B2 | Prodrugs with a tridentate self-immolative linker | THE GENERAL HOSPITAL CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | PERIMETER SOLUTIONS, LP (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2022035805-A1 | SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
| US-20220041597-A1 | INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X | FORMA THERAPEUTICS, INC. | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | SLC6A12, SLC9A2, SLC11A2 | CA2 13/4885USP2 1230/4885ATM 1067/4885 |
| US-20220041597-A1 | INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X | MCL1, HSPA9, USP10 | CA2 4728/4885USP2 147/4885ATM 99/4885 |
| US-12636373-B2 | Prodrugs with a tridentate self-immolative linker | AURKC, MBOAT7, MBOAT1 | CA2 805/4885USP2 1724/4885ATM 385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.